Biogen

120 results

Travel-related stocks performed well despite increasing uncertainty over summer bookings. Photograph: Bryan O’Brien

European stocks scaled a record high on Friday, buoyed by hopes that major central banks will remain accommodative despite signs of rising inflation,(...)

It was a good day for airline stocks as the US loosened restrictions on travel. Photograph: Steve Parsons/PA Wire

World stocks hovered near record highs as markets awaited a policy announcement from the European Central Bank and US inflation data, both due on Thur(...)

Biogen has slapped a $56,000 (€45,000) price tag for a year’s supply of the medicine, to be called Aduhelm. Photograph: iStock

The Alzheimer’s Society of Ireland says that there are about 64,000 people living with dementia in the State, an umbrella term it uses for a range of (...)

Henry Magendantz, a patient in the trial of Biogen’s Alzheimer’s drug, aducanumab, after an infusion. Photograph: Kayana Szymczak/The New York Times

Biogen’s decision to price its newly approved Alzheimer’s treatment at $56,000-a-year has reignited the debate over the high cost of drugs in the US, (...)

Trading in Biogen’s shares was halted ahead of the decision but shares in Japanese pharmaceutical company Eisai, which it partnered with, surged 45 per cent.

US regulators have approved an Alzheimer’s drug from Biogen that split the scientific community, marking a significant moment for sufferers of the di(...)

Ireland’s tax authorities have rejected an offer from consumer healthcare group Perrigo to settle an outstanding €1.64 billion tax bill.  Photograph: Adam Bird/Bloomberg via Getty Images

The State’s tax authorities have rejected an offer from consumer healthcare group Perrigo to settle an outstanding €1.64 billion tax bill. The decis(...)

Perrigo has made an offer to settle a disputed €1.64 billion tax bill levied by Revenue. Photograph: Adam Bird/Bloomberg via Getty

Perrigo has made an offer to settle a disputed €1.64 billion tax bill levied by Revenue related to its purchase in 2013 of Elan Pharmaceuticals. Murr(...)

Kneat co-founder and chief executive Eddie Ryan: The company has experienced significant growth during the Covid crisis as it assists clients experiencing challenges around their on-premises applications.

Kneat, an Irish company that provides software for the life sciences, healthcare and other heavily regulated industries, has secured 22 million Canadi(...)

Warren Buffett’s Berkshire Hathaway placed a $5.7bn (€4.8bn) bet on four US pharmaceutical stocks in the third quarter. File photograph: Getty

Warren Buffett’s Berkshire Hathaway placed a $5.7 billion (€4.8 billion) bet on four US pharmaceutical stocks in the third quarter, as the billionaire(...)

Photograph: iStock

Japan’s Nikkei index on Friday ended at its highest level in 29 years, tracking strong moves in global equities, as investors hoped a gridlock in US (...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »